Corcept Therapeutics
(CORT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,235 | 8,993 | 10,073 | N/A | N/A |
| Marketable Securities | 16,799 | N/A | 1,504 | N/A | N/A |
| TOTAL | $52,912 | $9,341 | $11,743 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 1 | N/A | N/A |
| Investments And Advances | 3,160 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 52 | 942 | 38 | 0 | 0 |
| TOTAL | $3,212 | $942 | $38 | $N/A | $N/A |
| Total Assets | $56,124 | $10,283 | $11,781 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 630 | 936 | 322 | 0 | 0 |
| Accrued Expenses | 484 | 209 | 334 | N/A | N/A |
| TOTAL | $1,401 | $1,530 | $1,014 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 529 | 524 | 0 | 0 |
| TOTAL | $N/A | $529 | $524 | $N/A | $N/A |
| Total Liabilities | $1,401 | $2,059 | $1,538 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,687 | 22,642 | N/A | N/A | N/A |
| Common Shares | 23 | 9 | 9 | N/A | N/A |
| Retained earnings | -44,072 | -40,488 | -37,937 | N/A | N/A |
| Other shareholders' equity | -2,777 | 38,275 | 39,190 | 0 | 0 |
| TOTAL | $54,724 | $8,225 | $10,243 | $N/A | $N/A |
| Total Liabilities And Equity | $56,124 | $10,283 | $11,781 | $0 | $0 |